Biotech Values

[bio_neophyte]

RPRX - dewophile

"1. dilution is based on # shares issued, which is less than what many expected"

I was unware that many expected the Co. to sell the entire 5m shelf in the offering. I try not to make assumptions like these.

"2. the fact that less $ was raised now might speak to additional expected revenue from alternative sources (i.e. partnership(s)) in the near future"

Thank you for that insight.

Sorry if i sound cautious but what when i see posters throwing words around like fantastic and excellent (both rarities on this forum) on a basic PR i feel like i missed something hence the questions. Thanks again.